Park National Corp OH maintained its position in shares of CME Group Inc (NASDAQ:CME) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,025 shares of the financial services provider’s stock at the end of the first quarter. Park National Corp OH’s holdings in CME Group were worth $359,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Johnson Financial Group Inc. increased its position in shares of CME Group by 5.9% in the fourth quarter. Johnson Financial Group Inc. now owns 899 shares of the financial services provider’s stock worth $104,000 after buying an additional 50 shares during the period. Parallel Advisors LLC purchased a new position in shares of CME Group during the fourth quarter worth approximately $120,000. Bronfman E.L. Rothschild L.P. increased its stake in shares of CME Group by 4.0% in the third quarter. Bronfman E.L. Rothschild L.P. now owns 1,155 shares of the financial services provider’s stock valued at $121,000 after buying an additional 44 shares during the last quarter. Archford Capital Strategies LLC increased its stake in shares of CME Group by 5,492.0% in the fourth quarter. Archford Capital Strategies LLC now owns 1,398 shares of the financial services provider’s stock valued at $161,000 after buying an additional 1,373 shares during the last quarter. Finally, Advisors Preferred LLC bought a new stake in shares of CME Group during the third quarter valued at approximately $180,000. 80.06% of the stock is owned by institutional investors.
Shares of CME Group Inc (NASDAQ:CME) opened at 119.11 on Friday. CME Group Inc has a 52 week low of $90.69 and a 52 week high of $127.60. The firm has a market cap of $40.46 billion, a PE ratio of 26.29 and a beta of 0.88. The firm has a 50-day moving average of $120.33 and a 200 day moving average of $115.89.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, February 2nd. The financial services provider reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.03. The firm earned $913 million during the quarter, compared to analyst estimates of $881.46 million. CME Group had a return on equity of 7.28% and a net margin of 42.67%. CME Group’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.92 EPS. Equities research analysts predict that CME Group Inc will post $4.87 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Monday, March 27th. Stockholders of record on Friday, March 10th were given a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 2.22%. The ex-dividend date of this dividend was Wednesday, March 8th. This is a positive change from CME Group’s previous quarterly dividend of $0.60. CME Group’s payout ratio is currently 52.98%.
Several analysts recently commented on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $134.00 target price on shares of CME Group in a report on Thursday, March 30th. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Monday, March 20th. Deutsche Bank AG reduced their target price on shares of CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a report on Thursday, April 6th. JPMorgan Chase & Co. downgraded shares of CME Group from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 31st. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $128.00 target price on shares of CME Group in a report on Saturday, March 11th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $111.54.
In other CME Group news, insider Julie Winkler sold 5,888 shares of the business’s stock in a transaction dated Friday, February 24th. The stock was sold at an average price of $122.53, for a total value of $721,456.64. Following the completion of the transaction, the insider now owns 14,095 shares of the company’s stock, valued at approximately $1,727,060.35. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $117.85, for a total value of $294,625.00. Following the completion of the transaction, the chief financial officer now directly owns 40,995 shares of the company’s stock, valued at approximately $4,831,260.75. The disclosure for this sale can be found here. In the last three months, insiders sold 12,931 shares of company stock valued at $1,576,260. 0.61% of the stock is owned by insiders.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.